Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 8
Submit an article Journal homepage
218
Views
49
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma

Shrinivas Bishu National Institute of Mental Health, National Institutes of Health, MD, USACorrespondence[email protected]
,
Joanna M. Quigley College of Medicine, University of Nebraska Medical Center, NE, USA
,
Shreenath R. Bishu Department of Pathology, Northwestern University, IL, USA
,
Sarah M. Olsasky College of Medicine, University of Nebraska Medical Center, NE, USA
,
Richard A. Stem College of Medicine, University of Nebraska Medical Center, NE, USA
,
Valerie K. Shostrom College of Public Health, University of Nebraska Medical Center, NE, USA
,
Karen P. Holdeman Division of Nuclear Medicine, Department of Radiology, University of Nebraska Medical Center, NE, USA
,
Subash Paknikar Division of Nuclear Medicine, Department of Radiology, Creighton University Medical Center, NE, USA
,
James O. Armitage Section of Oncology and Hematology, Department of Medicine, University of Nebraska Medical Center, NE, USA
&
Jordan H. Hankins Division of Nuclear Medicine, Department of Radiology, University of Nebraska Medical Center, NE, USA
 show all
Pages 1548-1555 | Received 14 Sep 2006, Accepted 26 Apr 2007, Published online: 01 Jul 2009

Citations (49)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Ross Thomas Salvaris & Chan Yoon Cheah. (2022) Time to omit interim CT imaging during frontline chemoimmunotherapy for patients with follicular lymphoma?. Leukemia & Lymphoma 63:14, pages 3271-3273.
Read now
Yeye Zhou, Zixuan Zhao, Jihui Li, Bin Zhang, Shibiao Sang, Yiwei Wu & Shengming Deng. (2019) Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT in patients with follicular lymphoma. Cancer Management and Research 11, pages 6871-6885.
Read now
Ida Wong-Sefidan, Michelle Byrtek, Xiaolei Zhou, Jonathan W. Friedberg, Christopher R. Flowers, Andrew D. Zelenetz, Keith L. Dawson & Erin Reid. (2017) [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice. Leukemia & Lymphoma 58:4, pages 809-815.
Read now
Lale Kostakoglu, Andre Goy, Giovanni Martinelli, Dolores Caballero, Michael Crump, Gianluca Gaidano, Tara Baetz, Rena Buckstein, Gregg Fine, Guenter Fingerle-Rowson, Claude Berge, Deniz Sahin, Oliver Press & Laurie Sehn. (2017) FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study. Leukemia & Lymphoma 58:2, pages 372-381.
Read now
John F. Seymour, Judith Trotman & Michael S. Hofman. (2013) Evaluating the place of 18-fluoro-2-deoxy-d-glucose positron emission tomography scanning in primary staging and beyond in patients with follicular lymphoma. Leukemia & Lymphoma 54:10, pages 2093-2095.
Read now
Martin Hutchings. (2009) PET imaging in lymphoma. Expert Review of Hematology 2:3, pages 261-276.
Read now
Andrew Wirth. (2007) PET for follicular lymphoma: A work in progress!. Leukemia & Lymphoma 48:8, pages 1463-1464.
Read now

Articles from other publishers (42)

Merissa N. Zeman, Esma A. Akin, Reid W. Merryman & Heather A. Jacene. (2023) Interim FDG-PET/CT for Response Assessment of Lymphoma. Seminars in Nuclear Medicine 53:3, pages 371-388.
Crossref
Reid W. Merryman, Laure Michaud, Robert Redd, Patrizia Mondello, Hyesun Park, Gabriela Spilberg, Matthew Robertson, Eleanor Taranto, Gulrayz Ahmed, Matthew Chase, Erin Jeter, Inhye E. Ahn, Jennifer R. Brown, Jennifer Crombie, Matthew S. Davids, David C. Fisher, Eric Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Samuel Y. Ng, Oreofe O. Odejide, Erin M. Parry, Gilles Salles, Andrew D. Zelenetz, Philippe Armand, Heiko Schöder & Heather Jacene. (2023) Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma. HemaSphere 7:2, pages e826.
Crossref
A. Díaz-Silván, L.F. Otón-Sánchez, A.P. Caresia-Aróztegui, M. del Puig Cózar-Santiago, J. Orcajo-Rincón, M. de Arcocha-Torres, R.C. Delgado-Bolton & D. Cabello-García. (2022) Clinical application of [18F]FDG PET/CT in follicular lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 41:3, pages 202-212.
Crossref
A. Díaz-Silván, L.F. Otón-Sánchez, A.P. Caresia-Aróztegui, M. del Puig Cózar-Santiago, J. Orcajo-Rincón, M. de Arcocha-Torres, R.C. Delgado-Bolton & D. Cabello-García. (2022) Aplicación clínica de la [18F]FDG PET/TC en el linfoma folicular. Revista Española de Medicina Nuclear e Imagen Molecular 41:3, pages 202-212.
Crossref
Sun Ha Boo, Joo Hyun O, Soo Jin Kwon, Ie Ryung Yoo, Sung Hoon Kim, Gyeong Sin Park, Byung Ock Choi, Seung Eun Jung & Seok-Goo Cho. (2019) Predictive Value of Interim and End-of-Therapy 18F-FDG PET/CT in Patients with Follicular Lymphoma. Nuclear Medicine and Molecular Imaging 53:4, pages 263-269.
Crossref
Manar Hussein Abdel-Sattar, Omar Abdelaziz, Amr Othman Othman & Sherief Mohamed El-Refaei. (2018) The use of Deauville criteria in follow-up assessment of response to therapy in extra-nodal Non-Hodgkin's lymphoma. The Egyptian Journal of Radiology and Nuclear Medicine 49:1, pages 209-215.
Crossref
Shawn Karls, Hina Shah & Heather Jacene. (2018) PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up. Seminars in Nuclear Medicine 48:1, pages 37-49.
Crossref
Hugo J.A. Adams & Thomas C. Kwee. (2017) An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphoma. Seminars in Oncology 44:6, pages 404-419.
Crossref
Mateen C. Moghbel, Erik Mittra, Andrea Gallamini, Ryan Niederkohr, Delphine L. Chen, Katherine Zukotynski, Helen Nadel & Lale Kostakoglu. (2017) Response Assessment Criteria and Their Applications in Lymphoma: Part 2. Journal of Nuclear Medicine 58:1, pages 13-22.
Crossref
Hugo J. A. Adams, Rutger A. J. Nievelstein & Thomas C. Kwee. (2015) Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review. Annals of Hematology 95:1, pages 11-18.
Crossref
Martin Hutchings & Sally Barrington. (2015) FDG-PET for the early treatment monitoring, for final response and follow-up evaluation in lymphoma. Clinical and Translational Imaging 3:4, pages 271-281.
Crossref
Stefano Luminari, Luca Ceriani & Ulrich Dührsen. (2015) FDG-PET(CT)-adapted trials in non-Hodgkin lymphoma. Clinical and Translational Imaging 3:4, pages 295-307.
Crossref
Tarec Christoffer El-Galaly & Martin Hutchings. 2015. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 125 146 .
Zhou Lu, Michael Lin, Paul Downe, Shanley Chong & Silvia Ling. (2014) The prognostic value of mid- and post-treatment [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma. Annals of Nuclear Medicine 28:8, pages 805-811.
Crossref
Lale Kostakoglu & Bruce D. Cheson. (2014) Current role of FDG PET/CT in lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 41:5, pages 1004-1027.
Crossref
Christelle Tychyj-Pinel, Fabien Ricard, Michael Fulham, Marion Fournier, Michel Meignan, Thierry Lamy, Pierre Vera, Gilles Salles & Judith Trotman. (2014) PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study. European Journal of Nuclear Medicine and Molecular Imaging 41:3, pages 408-415.
Crossref
Junhee Pyo, Kyung Won Kim, Heather A. Jacene, Christopher G. Sakellis, Jennifer R. Brown & Annick D. Van den Abbeele. (2013) End-Therapy Positron Emission Tomography for Treatment Response Assessment in Follicular Lymphoma: A Systematic Review and Meta-analysis. Clinical Cancer Research 19:23, pages 6566-6577.
Crossref
Barbara W. Grant, Sin-Ho Jung, Jeffrey L. Johnson, Lale Kostakoglu, Eric Hsi, John C. Byrd, Jeffrey Jones, John P. Leonard, S. Eric Martin & Bruce D. Cheson. (2013) A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701. Cancer 119:21, pages 3797-3804.
Crossref
S. Luminari, I. Biasoli, L. Arcaini, A. Versari, C. Rusconi, F. Merli, M. Spina, A.J.M. Ferreri, P.L. Zinzani, A. Gallamini, S. Mastronardi, C. Boccomini, G. Gaidano, A.M. D'Arco, F. Di Raimondo, A.M. Carella, A. Santoro, P. Musto & M. Federico. (2013) The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Annals of Oncology 24:8, pages 2108-2112.
Crossref
Shamzah ArafSilvia Montoto. (2013) The use of interim 18 F-fluorodeoxyglucose PET to guide therapy in lymphoma . Future Oncology 9:6, pages 807-815.
Crossref
Pier Luigi Zinzani, Monia Marchetti, Atto Billio, Giovanni Barosi, Angelo Michele Carella, Mario Lazzarino, Maurizio Martelli, Alessandro Rambaldi, Luigi Rigacci, Corrado Tarella, Umberto Vitolo & Sante Tura. (2013) SIE , SIES , GITMO revised guidelines for the management of follicular lymphoma . American Journal of Hematology 88:3, pages 185-192.
Crossref
C. Bodet-Milin, T. Eug?ne, T. Gastinne, C. Bailly, S. Le Gouill, B. Dupas & F. Kraeber-Bod?r?. (2013) La place de la TEP au FDG dans l??valuation des lymphomes en 2012. Journal de Radiologie Diagnostique et Interventionnelle 94:2, pages 164-174.
Crossref
C. Bodet-Milin, T. Eug?ne, T. Gastinne, C. Bailly, S. Le Gouill, B. Dupas & F. Kraeber-Bod?r?. (2013) The role of FDG-PET scanning in assessing lymphoma in 2012. Diagnostic and Interventional Imaging 94:2, pages 158-168.
Crossref
Sally F. Barrington & N. George Mikhaeel. (2012) Imaging Follicular Lymphoma Using Positron Emission Tomography With [ 18 F]Fluorodeoxyglucose: To What Purpose? . Journal of Clinical Oncology 30:35, pages 4285-4287.
Crossref
Jehan DupuisAlina Berriolo-RiedingerAnne JulianPauline BriceChristelle Tychyj-PinelHervé TillyNicolas MounierAndrea GallaminiPierre FeugierPierre SoubeyranPhilippe ColombatGuy LaurentNathalie BerengerRene-Olivier CasasnovasPierre VeraGaetano PaoneLuc XerriGilles SallesCorinne HaiounMichel Meignan. (2012) Impact of [ 18 F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High–Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS . Journal of Clinical Oncology 30:35, pages 4317-4322.
Crossref
Lale Kostakoglu. 2012. A Case-Based Approach to PET/CT in Oncology. A Case-Based Approach to PET/CT in Oncology 329 365 .
Egesta Lopci, Lucia Zanoni, Arturo Chiti, Cristina Fonti, Ivan Santi, Pier Luigi Zinzani & Stefano Fanti. (2012) FDG PET/CT predictive role in follicular lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 39:5, pages 864-871.
Crossref
A. Afshar-Oromieh, C. Kratochwil, U. Haberkorn & F.L. Giesel. (2012) Stellenwert der PET/CT in der LymphomdiagnostikImportance of PET/CT in lymphoma diagnostics. Der Radiologe 52:4, pages 338-346.
Crossref
C. Bodet-Milin, T. Eugène, T. Gastinne, E. Frampas, S. Le Gouill & F. Kraeber-Bodéré. (2012) FDG-PET in Follicular Lymphoma Management. Journal of Oncology 2012, pages 1-8.
Crossref
Juliano Julio Cerci, Lucia Zanoni, José C. Meneghetti & Stefano Fanti. (2012) FDG-PET in Lymphoma: Nuclear Medicine Perspective. PET Clinics 7:1, pages 21-33.
Crossref
Judith TrotmanMarion FournierThierry LamyJohn Francis SeymourAnne SonetAndrea JanikovaOfer ShpilbergEmmanuel GyanHervé TillyJane EstellCecily ForsythDidier DecaudinBettina FabianiJean GabarreBruno SallesEric Van Den NesteDanielle CanioniEtienne GarinMichael FulhamThierry Vander BorghtGilles Salles. (2011) Positron Emission Tomography–Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants. Journal of Clinical Oncology 29:23, pages 3194-3200.
Crossref
M.S. Hofman & R.J. Hicks. (2011) Imaging in follicular NHL. Best Practice & Research Clinical Haematology 24:2, pages 165-177.
Crossref
Ludovic Le Dortz, Sophie De Guibert, Sahar Bayat, Anne Devillers, Roch Houot, Yan Rolland, Marc Cuggia, Florence Le Jeune, Haïfa Bahri, Marie-Luce Barge, Thierry Lamy & Etienne Garin. (2010) Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 37:12, pages 2307-2314.
Crossref
Sandip Basu. (2009) Early FDG-PET response–adapted risk stratification and further therapeutic decision-making in lymphoma: will this replace the established prognostic indices and be the standard-of-care in clinical management?. European Journal of Nuclear Medicine and Molecular Imaging 36:12, pages 2089-2090.
Crossref
C. Bodet-Milin, P.-Y. Salaun, C. Crespin, J.-P. Vuillez & F. Kraeber-Bod?r?. (2009) La place de la TEP au FDG dans l??valuation des lymphomes. M?decine Nucl?aire 33:8, pages 486-490.
Crossref
L. Le Dortz, S. de Guibert, A. Devillers, Y. Rolland, S. Bayat, F. Prigent, H. Bahri, T. Hervouet, T. Lamy & E. Garin. (2009) Apport de la tomographie ? ?mission de positons au 18F-fluorod?oxyglucose dans la prise en charge des lymphomes folliculaires. M?decine Nucl?aire 33:6, pages 363-374.
Crossref
Martin Hutchings & Sally F. Barrington. (2009) PET/CT for Therapy Response Assessment in Lymphoma. Journal of Nuclear Medicine 50:Suppl 1, pages 21S-30S.
Crossref
Andrea Janikova, Karol Bolcak, Tomas Pavlik, Jiri Mayer & Zdenek Kral. (2008) Value of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Follicular Lymphoma: The End of a Dilemma?. Clinical Lymphoma and Myeloma 8:5, pages 287-293.
Crossref
Lale Kostakoglu. (2008) [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Lymphomas. Clinical Lymphoma and Myeloma 8:5, pages 273-276.
Crossref
Jean-François Chatal, Françoise Kraeber-Bodéré & Jacques Barbet. (2008) Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?. European Journal of Nuclear Medicine and Molecular Imaging 35:7, pages 1236-1239.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:2, pages 115-122.
Crossref
Martin Allen-Auerbach, Sven de Vos & Johannes Czernin. (2008) The Impact of Fluorodeoxyglucose?Positron Emission Tomography in Primary Staging and Patient Management in Lymphoma Patients. Radiologic Clinics of North America 46:2, pages 199-211.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.